Table of Content

Open Access iconOpen Access

ARTICLE

Circulating biomarkers of left ventricular hypertrophy in pediatric coarctation of the aorta

Benjamin S. Frank1, Tracy T. Urban2, Karlise Lewis2, Suhong Tong3, Courtney Cassidy4, Max B. Mitchell5, Christopher S. Nichols6, Jesse A. Davidson1

1 Division of Cardiology, Department of Pediatrics, University of Colorado Denver, Aurora, Colorado
2 Children’s Hospital Colorado Research Institute, Aurora, Colorado
3 Department of Biostatistics, University of Colorado Denver, Aurora, Colorado
4 Department of Pediatric Cardiology, Children’s Hospital Colorado, Aurora, Colorado
5 Department of Surgery, University of Colorado Denver, Aurora, Colorado
6 Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado

* Corresponding Author: Benjamin S. Frank, MD, Division of Cardiology, Department of Pediatrics, University of Colorado Denver, 13123 E. 16th Ave, Box B100, Aurora, CO, 80045. Email: email

Congenital Heart Disease 2019, 14(3), 446-453. https://doi.org/10.1111/chd.12744

Abstract

Objective: Patients undergoing surgical repair of aortic coarctation have a 50% risk of pathologic left ventricular remodeling (increased left ventricular mass or relative wall thickness). Endothelin 1, ST2, galectin 3, norepinephrine and B‐natriuretic pep‐ tide are biomarkers that have been associated with pathologic LV change in adult populations but their predictive value following pediatric coarctation repair are not known.
Hypothesis: Biomarker levels at coarctation repair will predict persistent left ven‐ tricular remodeling at 1‐year follow up.
Design: Prospective, cohort study of 27 patients’ age 2 days‐12 years with coarcta‐ tion of the aorta undergoing surgical repair. Echocardiograms were performed pre‐ operation, postoperation, and at 1‐year follow‐up. Plasma biomarker levels were measured at the peri‐operative time points. Association between biomarker concen‐ trations and echocardiographic parameters was assessed.
Results: Neither left ventricular mass index nor relative wall thickness varied from pre‐op to post‐op. At pre‐op, relative wall thickness was elevated in 52% and left ventricular mass index was elevated in 22%; at follow‐up, relative wall thickness was elevated in 13% and left ventricular mass index was elevated in 8%. Presence of re‐ sidual coarctation did not predict left ventricular remodeling (AUC 0.59; P > .05). Multivariable receiver operating characteristic curve combining pre‐op ST2 and en‐ dothelin 1 demonstrated significant predictive ability for late pathologic left ven‐ tricular remodeling (AUC 0.85; P = .02).
Conclusions: Persistent left ventricular hypertrophy and abnormal relative wall thick‐ ness at intermediate‐term follow‐up was rare compared to previous studies. A model combining pre‐op endothelin 1 and ST2 level demonstrated reasonable accuracy at predicting persistent abnormalities in this cohort. Larger studies will be needed to validate this finding and further explore the mechanism of persistent left ventricular remodeling in this population.

Keywords


Cite This Article

Frank, B. S., Urban, T. T., Lewis, K., Tong, S., Cassidy, C. et al. (2019). Circulating biomarkers of left ventricular hypertrophy in pediatric coarctation of the aorta. Congenital Heart Disease, 14(3), 446–453. https://doi.org/10.1111/chd.12744



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1337

    View

  • 1067

    Download

  • 0

    Like

Share Link